| 12-28-2010 12:11 PM CET - Health & Medicine |
|
ENCITE Scientific Symposium “Imaging cellular decisions”
Press release from: EIBIR gGmbH

The EU project ENCITE, co-ordinated by EIBIR, is co-funded by the European Commission within the 7th Framework Programme.
The ENCITE consortium is very pleased to announce the ENCITE Scientific Symposium ‘Imaging Cellular Decisions'
Date: 27 March 2011, 09:00 - 17:00
Venue: WEIZMANN Institute of Science, Rehovot/Israel
This one-day symposium will expose the interested research community within Europe and Israel to the latest advanced technologies that provide temporal and spatial information on cell fate from the living organism.
All interested persons are very welcome to attend this open symposium, participation is free of charge, registration is required.
For registration please click here: www.encite.org/html/img/pool/ENCITE_Registration_external...
For information on accommodation, meeting venue, transfer etc. please click here: www.encite.org/html/img/pool/Information_to_externals.pdf
Further information on other ENCITE events can be found online at www.encite.org/cms/website.php?id=/en/index/training_plat...
ENCITE project
www.encite.org/cms/website.php
The European Institute for Biomedical Imaging Research (EIBIR) was established by the European Society of Radiology in 2006 as a non-profit limited liability company based in Vienna.
Our ambition is to bridge basic research to clinical research as well as to technological and pharmacologic development.
EIBIR functions as coordinator for research in the field of biomedical imaging and facilitates consortia as well as programme partnerships. Research projects have been successfully submitted within the 7th framework programme of the EU, for which EIBIR is in charge of coordination and project management (HAMAM, ENCITE, PEDDOSE.NET, Euro-BioImaging).
EIBIR has set itself the target to establish and support educational and exchange programmes for researchers as well as to organise workshops and meetings on relevant research subjects.
EIBIR is also active in the field of EU lobbying and aims to influence the content of future research programmes for the benefit of biomedical imaging through a fruitful dialogue with EU Institutions, thus reinforcing Europe’s position in cutting-edge research.
EIBIR gGmbH
Neutorgasse 9/2a
AT-1010 Vienna
Austria
office@eibir.org
+43-1-533-40-64-29
www.eibir.org
www.encite.org
News-ID: 156710
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
EIBIR gGmbH
Comments about openPR
OpenPR ist the nicest and most clearly laid out PR platform I have seen to this day. The press releases are displayed very nicely and clearly and without any unnecessary frills.
The updates are fast and the finished release looks appealing and is clearly legible.
Even with 16 years of experience one discovers new things from time to time.
Congratulations!
Gabriele Ketterl,Director Marketing & PR, Menads
The updates are fast and the finished release looks appealing and is clearly legible.
Even with 16 years of experience one discovers new things from time to time.
Congratulations!
Gabriele Ketterl,Director Marketing & PR, Menads

